Will SARS-CoV-2 impact the incidence and nature of other respiratory infections?
Author:
Affiliation:
1. College of Pharmacy, Al Ain University, Abu Dhabi, United Arab Emirates
2. AAU Health and Biomedical Research Center, Al Ain University, Abu Dhabi, United Arab Emirates
Publisher
Informa UK Limited
Subject
Immunology,Immunology and Allergy
Link
https://www.tandfonline.com/doi/pdf/10.1080/1744666X.2023.2263646
Reference20 articles.
1. World Health Organisation. WHO. WHO coronavirus (COVID-19) dashboard [Internet]. 2023 [cited 2023 Jul 28]. Available from: https://covid19.who.int
2. Innate immunity: the first line of defense against SARS-CoV-2
3. Severe COVID-19 is a T cell immune dysregulatory disorder triggered by SARS-CoV-2
4. Innate lymphoid cells and disease tolerance in SARS-CoV-2 infection;Silverstein NJ;medRxiv,2021
5. SARS‐CoV2 pneumonia recovery is linked to expansion of innate lymphoid cells type 2 expressing CCR10
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Beyond resistance: assessing sulbactam-durlobactam’s role in today’s clinical landscape;Expert Review of Anti-infective Therapy;2024-05-11
2. Antiretroviral therapy response: exploring the potential influence of SARS-CoV-2;Expert Review of Clinical Pharmacology;2024-02-28
3. Strategies for reducing chronic disease burden during pandemics;Current Medical Research and Opinion;2023-12-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3